Oncol Lett. 2010 Nov;1(6):1061-1066. doi: 10.3892/ol.2010.171. Epub 2010 Sep 09.

Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas.

Oncology letters

Kyoko Tanaka, Mikio Mikami, Daisuke Aoki, Kazushige Kiguchi, Isamu Ishiwata, Masao Iwamori

PMID: 22870113 PMCID: PMC3412467 DOI: 10.3892/ol.2010.171

Abstract

To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV(6)NeuAcα-nLc(4)Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.

References

1. Biochem Biophys Res Commun. 1999 Nov 2;264(3):619-21 - PubMed
2. J Biol Chem. 1992 Feb 25;267(6):4152-60 - PubMed
3. Br J Cancer. 1985 Jul;52(1):131-3 - PubMed
4. Cancer Sci. 2005 Jan;96(1):26-30 - PubMed
5. Glycoconj J. 2008 Oct;25(7):675-83 - PubMed
6. Glycobiology. 2000 Apr;10(4):375-82 - PubMed
7. J Biol Chem. 1993 Apr 5;268(10):7011-8 - PubMed
8. Jpn J Cancer Res. 1997 Jul;88(7):669-77 - PubMed
9. J Biochem. 2007 Mar;141(3):309-17 - PubMed
10. Histol Histopathol. 2002 Jan;17(1):191-8 - PubMed
11. Science. 1981 Apr 3;212(4490):53-5 - PubMed
12. J Biol Chem. 2001 Nov 9;276(45):41527-42 - PubMed
13. Nature. 1991 Jan 17;349(6306):196-7 - PubMed
14. Cancer Sci. 2006 Dec;97(12):1321-6 - PubMed
15. Cancer Res. 1992 Jan 15;52(2):416-21 - PubMed
16. Cancer Sci. 2003 Oct;94(10):871-6 - PubMed
17. J Cell Biol. 1991 Jun;113(5):1213-21 - PubMed
18. J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):99-104 - PubMed
19. FEBS Lett. 1999 Dec 10;463(1-2):92-6 - PubMed

Show all 19 references

Publication Types

• Journal Article